These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20100957)

  • 21. The effect of race and rural residence on prostate cancer treatment choice among men in Georgia.
    Steenland K; Goodman M; Liff J; Diiorio C; Butler S; Roberts P; Smith JL; Ekwueme D; Hall IJ
    Urology; 2011 Mar; 77(3):581-7. PubMed ID: 21377006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
    Swords K; Wallen EM; Pruthi RS
    Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnic minorities (African American and Hispanic) males prefer prostate cryoablation as aggressive treatment of localized prostate cancer.
    Kim FJ; Werahera PN; Sehrt DE; Gustafson D; Silva RD; Molina WR
    Can J Urol; 2014 Jun; 21(3):7305-11. PubMed ID: 24978362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.
    Demark-Wahnefried W; Schildkraut JM; Iselin CE; Conlisk E; Kavee A; Aldrich TE; Lengerich EJ; Walther PJ; Paulson DF
    Cancer; 1998 Jul; 83(2):320-30. PubMed ID: 9669815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.
    Vijayakumar S; Weichselbaum R; Vaida F; Dale W; Hellman S
    Cancer J Sci Am; 1996; 2(4):225-33. PubMed ID: 9166537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.
    Zeliadt SB; Potosky AL; Etzioni R; Ramsey SD; Penson DF
    Urology; 2004 Dec; 64(6):1171-6. PubMed ID: 15596192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
    Fu AZ; Tsai HT; Haque R; Ulcickas Yood M; Van Den Eeden SK; Cassidy-Bushrow AE; Zhou Y; Keating NL; Smith MR; Aaronson DS; Potosky AL
    World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial Disparities in Active Surveillance for Prostate Cancer.
    Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
    J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
    Lubeck DP; Grossfeld GD; Carroll PR
    Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy.
    Tward JD; O'Neil B; Boucher K; Kokeny K; Lowrance WT; Lloyd S; Cannon D; Stephenson RA; Agarwal N; Farr T; Petragallo R; Sherar NZ; Kunz I; Hofer A; Courdy S; Shrieve DC; Dechet C
    Clin Genitourin Cancer; 2020 Aug; 18(4):274-283.e5. PubMed ID: 32335059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
    Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
    Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
    Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani AB; Kucuk ON; Master VA; Gillespie TW; Filson CP
    Urol Oncol; 2017 May; 35(5):250-256. PubMed ID: 28089387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
    Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL
    J Natl Cancer Inst; 2001 Mar; 93(5):388-95. PubMed ID: 11238701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.
    Obirieze AC; Moten A; Allen D; Ahaghotu CA
    J Racial Ethn Health Disparities; 2015 Sep; 2(3):295-302. PubMed ID: 26863460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE.
    Park S; Meng MV; Elkin EP; Speight JL; DuChane J; Carroll PR
    J Urol; 2005 Nov; 174(5):1802-7. PubMed ID: 16217291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.
    Wong AT; Safdieh JJ; Rineer J; Weiner J; Schwartz D; Schreiber D
    Int Urol Nephrol; 2015 Oct; 47(10):1629-34. PubMed ID: 26329748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.